While large language models have been around for a while, OpenAI's ChatGPT has sparked unprecedented interest in their application in diverse domains, including problems in drug discovery.
In these early days, ChatGPT and similar models are showing promising signs:
Written in collab with Fierce Biotech, the whitepaper discusses the potential and possibilities the model can bring to make drug research a less laborious process. Here we demystify it’s underlying technology, hypothesize on it’s applications in various steps of discovery and discuss limitations.
While large language models have been around for a while, OpenAI's ChatGPT has sparked unprecedented interest in their application in diverse domains, including problems in drug discovery.
In these early days, ChatGPT and similar models are showing promising signs:
Written in collab with Fierce Biotech, the whitepaper discusses the potential and possibilities the model can bring to make drug research a less laborious process. Here we demystify it’s underlying technology, hypothesize on it’s applications in various steps of discovery and discuss limitations.
.svg)
.svg)
%201%20(1).svg)
.svg)
%201.svg){kind=icon}
.svg)
%20(1).svg)
